TIL
Price
$15.00
Change
-$1.63 (-9.80%)
Updated
Apr 4, 04:31 PM (EDT)
Capitalization
119.55M
XNCR
Price
$8.68
Change
-$0.24 (-2.69%)
Updated
Apr 4, 04:51 PM (EDT)
Capitalization
627.11M
34 days until earnings call
Ad is loading...

TIL vs XNCR

Header iconTIL vs XNCR Comparison
Open Charts TIL vs XNCRBanner chart's image
Instil Bio
Price$15.00
Change-$1.63 (-9.80%)
Volume$400
Capitalization119.55M
Xencor
Price$8.68
Change-$0.24 (-2.69%)
Volume$3.5K
Capitalization627.11M
TIL vs XNCR Comparison Chart
Loading...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
TIL vs. XNCR commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TIL is a Hold and XNCR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (TIL: $16.63 vs. XNCR: $8.92)
Brand notoriety: TIL and XNCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: TIL: 89% vs. XNCR: 124%
Market capitalization -- TIL: $119.55M vs. XNCR: $627.11M
TIL [@Biotechnology] is valued at $119.55M. XNCR’s [@Biotechnology] market capitalization is $627.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TIL’s FA Score shows that 1 FA rating(s) are green whileXNCR’s FA Score has 1 green FA rating(s).

  • TIL’s FA Score: 1 green, 4 red.
  • XNCR’s FA Score: 1 green, 4 red.
According to our system of comparison, TIL is a better buy in the long-term than XNCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

TIL’s TA Score shows that 2 TA indicator(s) are bullish while XNCR’s TA Score has 4 bullish TA indicator(s).

  • TIL’s TA Score: 2 bullish, 7 bearish.
  • XNCR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, XNCR is a better buy in the short-term than TIL.

Price Growth

TIL (@Biotechnology) experienced а -14.10% price change this week, while XNCR (@Biotechnology) price change was -22.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.96%. For the same industry, the average monthly price growth was -16.83%, and the average quarterly price growth was -18.34%.

Reported Earning Dates

TIL is expected to report earnings on Mar 04, 2024.

XNCR is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-10.96% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XNCR($627M) has a higher market cap than TIL($120M). TIL YTD gains are higher at: -12.886 vs. XNCR (-61.184). TIL has higher annual earnings (EBITDA): -62.53M vs. XNCR (-186.17M). XNCR has more cash in the bank: 498M vs. TIL (113M). TIL has less debt than XNCR: TIL (86.9M) vs XNCR (232M). XNCR has higher revenues than TIL: XNCR (110M) vs TIL (0).
TILXNCRTIL / XNCR
Capitalization120M627M19%
EBITDA-62.53M-186.17M34%
Gain YTD-12.886-61.18421%
P/E RatioN/AN/A-
Revenue0110M-
Total Cash113M498M23%
Total Debt86.9M232M37%
FUNDAMENTALS RATINGS
TIL vs XNCR: Fundamental Ratings
TIL
XNCR
OUTLOOK RATING
1..100
6551
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
79
Overvalued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
6095
P/E GROWTH RATING
1..100
1004
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TIL's Valuation (16) in the Precious Metals industry is somewhat better than the same rating for XNCR (79) in the Biotechnology industry. This means that TIL’s stock grew somewhat faster than XNCR’s over the last 12 months.

TIL's Profit vs Risk Rating (95) in the Precious Metals industry is in the same range as XNCR (100) in the Biotechnology industry. This means that TIL’s stock grew similarly to XNCR’s over the last 12 months.

TIL's SMR Rating (97) in the Precious Metals industry is in the same range as XNCR (97) in the Biotechnology industry. This means that TIL’s stock grew similarly to XNCR’s over the last 12 months.

TIL's Price Growth Rating (60) in the Precious Metals industry is somewhat better than the same rating for XNCR (95) in the Biotechnology industry. This means that TIL’s stock grew somewhat faster than XNCR’s over the last 12 months.

XNCR's P/E Growth Rating (4) in the Biotechnology industry is significantly better than the same rating for TIL (100) in the Precious Metals industry. This means that XNCR’s stock grew significantly faster than TIL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
TILXNCR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
66%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 19 days ago
84%
Bullish Trend 16 days ago
72%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
TIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XNCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RLGYX9.93N/A
N/A
Russell Inv Global Equity Y
GLIFX16.70N/A
N/A
Lazard Global Listed Infrastructure Inst
TVFVX60.47N/A
N/A
Third Avenue Value Investor
SRUIX13.32N/A
N/A
Meeder Spectrum Institutional
AIHHX6.79N/A
N/A
Aristotle Small/Mid Cap Equity I-2